- page
- file
- press_release The Care Quality Commission (CQC) has again rated Two Rivers Care Home inadequate and kept it in special measures, following an inspection in February and March. As a result, CQC are also taking further regulatory action which will be published when legally able to do so.… CQC takes further action to protect people at Finchley care home The Care Quality Commission (CQC) has …
- press_release The Care Quality Commission (CQC) has dropped the rating for The Willows care home from good to inadequate and issued three warning notices following an inspection in March.… CQC act to protect people at Ipswich care home The Care Quality Commission (CQC) has dropped the rating for The …
- press_release The Care Quality Commission (CQC) has published a report following an assessment of Cilantro suite at Birmingham and Solihull Mental Health NHS Foundation Trust in April.… CQC carries out assessment of specialist eating disorder service at … Trust in April. Cilantro Suite is a ten-bed mixed sex ward for people over the age of 18 with a diagnosis of eating … between 8am and 4pm, Monday to Friday. The inspection was carried out as part of CQC’s continual checks on the safety …
- publication Our recommendations for health and care services, national bodies and government, and police services.
- publication The section of 2023 annual report on the safer use of controlled drugs looking at national trends.… drugs in Schedules 2 to 5 in 2023 Total controlled drug items prescribed by NHS primary care services: … in prescribing of controlled drugs in 2023 Controlled drug Change Total items prescribed in 2023 Total items … in prescribing of controlled drugs in 2023 Controlled drug Change Total items prescribed in 2023 Total items …
- publication The section of 2023 annual report on the safer use of controlled drugs looking at key issues found.
- publication The section of 2023 annual report on the safer use of controlled drugs looking at our oversight activity.
- publication Our 2023 annual report on the safer use of controlled drugs highlights our regulatory oversight activities and inspection findings.
2 of 1092